Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Avita Medical (NASDAQ:RCEL) Earns Outperform Rating from Analysts at Northland Securities

Summary by defenseworld.net
Northland Securities began coverage on shares of Avita Medical (NASDAQ:RCEL – Free Report) in a report issued on Thursday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $10.00 price target on the stock. A number of other research analysts have also recently issued reports on the stock. Lake Street Capital lifted their price target on shares of Avita Medical from $3.00 to $3.50 and gave the company a “hold” rating in…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Sunday, March 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal